Form D · Pharmaceuticals

ADASTRA PHARMACEUTICALS, INC.

San Diego, CA · CIK 0001386218

Offering snapshot reported Apr 24, 2019 · SEC filing

Reported sold
$2.25M
Offering amount: $12M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 12, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 24, 2019Initial$2,250,223No comparison3SEC filing
Nov 15, 2016Initial$3,261,352No comparison3SEC filing
Sep 2, 2015Initial$13,058,784No comparison7SEC filing
Jul 17, 2015Initial$1,201,200No comparison5SEC filing
Aug 8, 2012Initial$4,000,000No comparison4SEC filing
Feb 4, 2010Initial$5,000,000No comparison7SEC filing
Mar 20, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jan 4, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-338035

Source: Form D, filed Apr 24, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Dennis Bilski Executive
Grigory Borisenko Director
Mauro Bove Director
Ralph E. Christoffersen Director
Chris E. Christoffersen Director
Ralph E. Christoffersen, Ph.D. Director
Thomas M. Estok Director
Kim P. Kamdar Director
Kim P. Kamdar, Ph.D. Director
Tracy Lawhon Executive
Chris Le Masters Executive
Scott Megaffin Director, Executive
Tracy Parrott Executive
Dennis Podlesak Director
Lynne R. Rollins Executive
Alain Schreiber Director
Alain B. Schreiber, M.D. Director
Eckard Weber Director
Eckard Weber, M.D. Director
Evgeny Zaytsev, M.D. Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
12481 High Bluff Drive, Suite 150
San Diego, CA, 92130